MXPA03009273A - AGENTE PARA EL TRATAMIENTO OFTaLMICO TOPICO DE LAS ENFERMEDADES INFLAMATORIAS OCULARES. - Google Patents
AGENTE PARA EL TRATAMIENTO OFTaLMICO TOPICO DE LAS ENFERMEDADES INFLAMATORIAS OCULARES.Info
- Publication number
- MXPA03009273A MXPA03009273A MXPA03009273A MXPA03009273A MXPA03009273A MX PA03009273 A MXPA03009273 A MX PA03009273A MX PA03009273 A MXPA03009273 A MX PA03009273A MX PA03009273 A MXPA03009273 A MX PA03009273A MX PA03009273 A MXPA03009273 A MX PA03009273A
- Authority
- MX
- Mexico
- Prior art keywords
- agent
- inflammatory diseases
- topical ophthalmic
- ocular inflammatory
- ophthalmic treatment
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28316901P | 2001-04-12 | 2001-04-12 | |
| PCT/JP2002/003664 WO2002085359A1 (en) | 2001-04-12 | 2002-04-12 | Agent for topical ophthalmic treatment of ocular inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03009273A true MXPA03009273A (es) | 2004-02-12 |
Family
ID=23084835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03009273A MXPA03009273A (es) | 2001-04-12 | 2002-04-12 | AGENTE PARA EL TRATAMIENTO OFTaLMICO TOPICO DE LAS ENFERMEDADES INFLAMATORIAS OCULARES. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20020187998A1 (enExample) |
| EP (1) | EP1379247A1 (enExample) |
| JP (1) | JP2004529928A (enExample) |
| KR (1) | KR20040007494A (enExample) |
| CN (1) | CN1503671A (enExample) |
| AR (1) | AR033151A1 (enExample) |
| BR (1) | BR0208939A (enExample) |
| CA (1) | CA2445508A1 (enExample) |
| MX (1) | MXPA03009273A (enExample) |
| NO (1) | NO20034560L (enExample) |
| NZ (1) | NZ529255A (enExample) |
| WO (1) | WO2002085359A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1406700A1 (en) | 2001-07-06 | 2004-04-14 | Sucampo AG | Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| RU2004118424A (ru) * | 2001-11-19 | 2005-05-10 | Новартис АГ (CH) | Применение аскомицина для лечения блефарита |
| BR0313425A (pt) * | 2002-08-09 | 2005-07-05 | Sucampo Pharmaceuticals Inc | Composição oftálmica para tratamento de alergia ocular, uso do composto de macrolìdeo e pacote comercial |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| AR042890A1 (es) * | 2003-01-16 | 2005-07-06 | Sucampo Pharmaceuticals Inc | Metodo de tratamiento del ojo seco con una composicion oftalmica que contiene un compuesto macrolido |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| JP2007505932A (ja) | 2003-09-18 | 2007-03-15 | マクサイト， インコーポレイテッド | 経強膜送達 |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| CA2597590A1 (en) | 2005-02-09 | 2006-08-17 | Macusight, Inc. | Formulations for ocular treatment |
| KR101478164B1 (ko) | 2006-02-09 | 2014-12-31 | 산텐 세이야꾸 가부시키가이샤 | 안정한 제제와 그 제조 및 사용 방법 |
| AU2007230964B2 (en) * | 2006-03-23 | 2012-07-19 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| US8536190B2 (en) * | 2007-01-30 | 2013-09-17 | Allergan, Inc. | Treating unwanted ocular conditions using an ascomycin macrolactam |
| WO2015188126A1 (en) * | 2014-06-06 | 2015-12-10 | The Schepens Eye Research Institute, Inc. | Compositions and methods for treating tumors and immune based inflammatory diseases |
| HUE048564T2 (hu) * | 2015-01-26 | 2020-08-28 | Bausch & Lomb | Szemészeti szuszpenzió készítmény |
| KR101710412B1 (ko) | 2015-09-15 | 2017-02-27 | 인제대학교 산학협력단 | Ycg063을 유효성분으로 함유하는 염증성 안구질환 예방 또는 치료용 약학조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| ZA905202B (en) * | 1989-07-05 | 1991-04-24 | Fujisawa Pharmaceutical Co | Aqueous liquid composition for external use |
| ATE126803T1 (de) * | 1989-11-09 | 1995-09-15 | Sandoz Ag | Heteroatome enthaltende tricyclische verbindungen. |
| CA2054983A1 (en) * | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Suspendible composition and process for preparing the same |
| ES2154262T3 (es) * | 1991-04-26 | 2001-04-01 | Fujisawa Pharmaceutical Co | Uso de compuestos macrolidos para enfermedades oculares. |
| AR004480A1 (es) * | 1995-04-06 | 1998-12-16 | Amico Derin C D | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen |
-
2002
- 2002-04-11 AR ARP020101334A patent/AR033151A1/es not_active Application Discontinuation
- 2002-04-12 KR KR10-2003-7013323A patent/KR20040007494A/ko not_active Withdrawn
- 2002-04-12 BR BR0208939-4A patent/BR0208939A/pt not_active IP Right Cessation
- 2002-04-12 NZ NZ529255A patent/NZ529255A/en unknown
- 2002-04-12 CA CA002445508A patent/CA2445508A1/en not_active Abandoned
- 2002-04-12 MX MXPA03009273A patent/MXPA03009273A/es unknown
- 2002-04-12 WO PCT/JP2002/003664 patent/WO2002085359A1/en not_active Ceased
- 2002-04-12 EP EP02717124A patent/EP1379247A1/en not_active Withdrawn
- 2002-04-12 CN CNA028082001A patent/CN1503671A/zh active Pending
- 2002-04-12 JP JP2002582932A patent/JP2004529928A/ja not_active Abandoned
- 2002-04-12 US US10/120,515 patent/US20020187998A1/en not_active Abandoned
-
2003
- 2003-10-10 NO NO20034560A patent/NO20034560L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1379247A1 (en) | 2004-01-14 |
| JP2004529928A (ja) | 2004-09-30 |
| BR0208939A (pt) | 2004-04-20 |
| WO2002085359A1 (en) | 2002-10-31 |
| NZ529255A (en) | 2006-09-29 |
| NO20034560L (no) | 2003-12-09 |
| CA2445508A1 (en) | 2002-10-31 |
| US20020187998A1 (en) | 2002-12-12 |
| KR20040007494A (ko) | 2004-01-24 |
| AR033151A1 (es) | 2003-12-03 |
| CN1503671A (zh) | 2004-06-09 |
| NO20034560D0 (no) | 2003-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7215A (is) | Aðferðir til að meðhöndla nýæðarsjúkdóma í augum | |
| MXPA03002814A (es) | Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias. | |
| NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| PT1411926E (pt) | Inibidores de integrina para o tratamento de doencas oftalmicas | |
| SI1487828T1 (sl) | Morfolinil-sečninski derivati za uporabo pri zdravljenu vnetnih bolezni | |
| AU2002210385A1 (en) | Furazanyl-triazole derivates for the treatment of diseases | |
| PL364086A1 (en) | Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases | |
| NO20034560L (no) | Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer | |
| IL173351A0 (en) | Therapy of ocular disorders | |
| MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
| AU2002333510A1 (en) | Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases | |
| PL375564A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
| AU2003297363A1 (en) | Use of cathepsin k inhibitors for the treatment of glaucoma | |
| EP1410795A4 (en) | MEDICINE FOR THE TREATMENT OF ALLERGIC EYE DISEASES | |
| EP1252895A4 (en) | REMEDIES FOR OPHTHALMIC DISORDERS | |
| EP1423125A4 (en) | OESTROGENES NOT INDUCING FEMINIZATION AS PROTECTIVE AGENTS ON RETINA IN THE TREATMENT OF GLAUCOMA | |
| AU2003232844A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
| GB0222282D0 (en) | Therapeutic device for the treatment of symptons caused by diseases | |
| AU2002365654A1 (en) | Treatment of diseases via the skin | |
| EP1426060A4 (en) | REMEDIES FOR ALLERGIC DISEASES | |
| AU2002326120A1 (en) | Use of dmso in the treatment of neurodegenerative diseases caused by prions | |
| AU2002343689A1 (en) | Methods for treatment of inflammatory diseases | |
| AU2003300471A1 (en) | Methods for treating ocular diseases | |
| AU2002337195A1 (en) | Therapeutic device for treating symptoms caused by diseases | |
| AU2002346179A1 (en) | Remedies for allergic eye diseases |